ptxtherapeutics.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php

Meta Tags

Title	Home - PTX
Description	Prescient is an ASX-listed biotechnology company focused on improving outcomes for cancer patients by developing, licencing and collaborating on universal CAR-T therapies to treat a range of
Keywords	N/A

Server Information

WebSite	ptxtherapeutics.com
Host IP	172.67.148.216
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

ptxtherapeutics.com Valuation

US$3,252,884

Last updated: 2022-06-19 14:03:25

ptxtherapeutics.com has Semrush global rank of 3,253,822. ptxtherapeutics.com has an estimated worth of US$ 3,252,884, based on its estimated Ads revenue. ptxtherapeutics.com receives approximately 375,333 unique visitors each day. Its web server is located in United States, with IP address 172.67.148.216. According to SiteAdvisor, ptxtherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$3,252,884
Daily Ads Revenue	US$3,003
Monthly Ads Revenue	US$90,080
Yearly Ads Revenue	US$1,080,959
Daily Unique Visitors	25,023
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
ptxtherapeutics.com.	A	300	IP: 172.67.148.216
ptxtherapeutics.com.	A	300	IP: 104.21.55.137
ptxtherapeutics.com.	AAAA	300	IPV6: 2606:4700:3030::ac43:94d8
ptxtherapeutics.com.	AAAA	300	IPV6: 2606:4700:3035::6815:3789
ptxtherapeutics.com.	NS	86400	NS Record: kate.ns.cloudflare.com.
ptxtherapeutics.com.	NS	86400	NS Record: jason.ns.cloudflare.com.
ptxtherapeutics.com.	MX	300	MX Record: 0 ptxtherapeutics-com.mail.protection.outlook.com.
ptxtherapeutics.com.	TXT	300	TXT Record: MS=ms92499964
ptxtherapeutics.com.	TXT	300	TXT Record: v=spf1 ip4:175.45.129.37 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2022-06-19 14:03:25

Toggle menu HOME ABOUT US TECHNOLOGY PIPELINE INVESTORS Investor Centre Live Investor Briefing Corporate Governance And Directory SHARE PRICE AND ANNOUNCEMENTS NEWS AND MEDIA News Webcast Replays Extended Briefing: A Deeper Dive Into Prescient OmniCAR Explainer Peter MacCallum Collaboration Update PTX-100 update with Prof. Miles Prince CONTACT US Home Home Prescient Therapeutics (ASX:PTX) is focused on developing novel, personalised therapies against a range of cancers Stay Updated About Prescient Therapeutics Prescient’s universal CAR-T and targeted therapies are both personalised medicine approaches that seek to improve patient outcomes and provide new tools for clinicians in combating cancer. ABOUT US Watch: OmniCAR - Next-Gen CAR-T Platform Recent Investor Briefings 1st March, 2022 Extended Briefing: A Deeper Dive Into Prescient Our Science CAR-T Therapy CAR-T is a cell therapy which works by genetically modifying a patient’s own T-cells by a dding a new receptor (CAR) to

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 23:31:19 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Sat, 23 Oct 2021 00:31:19 GMT
Location: https://ptxtherapeutics.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Je%2FkIuZ46T66S6zi%2BpiO2HO9NZI%2FlE4Gfo8G%2BdJ3RzUo5zCPjVZHe3lggV%2BmDxemLPhjPnTyivWr9CVyoXHHSLjE0xslwHQowVkV%2FL7QV4kVBBdquQH%2FT5zMJ4%2F2X3z4dZQcKuGM"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a2684c02b376375-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Fri, 22 Oct 2021 23:31:21 GMT
content-type: text/html; charset=UTF-8
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
link: ; rel="https://api.w.org/", ; rel=shortlink
set-cookie: PHPSESSID=5b1a1287756618154be858af4690fd2a; path=/
accept-ranges: none
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=XT9%2Fj26OUYat5L8YdpfV5CCN%2Bj3D6Y0RF%2BKEhCWDO3uGs84S2QD503KD7i12E8rBGrlmybfnNuse%2F79%2B%2BckM3dstI6T5C1ETLvR93LL4CHwVS5PwjO%2F4UHIzUMHSYOQHamR3kfIc"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a2684c08db12b4b-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

ptxtherapeutics.com Whois Information

Domain Name: PTXTHERAPEUTICS.COM
Registry Domain ID: 1999212512_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-01-14T02:54:57Z
Creation Date: 2016-02-01T02:11:56Z
Registry Expiry Date: 2024-02-01T02:11:56Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: JASON.NS.CLOUDFLARE.COM
Name Server: KATE.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T12:44:07Z <<<

ptxtherapeutics.com valuation and analysis